Centogene (CNTG) Short Interest Ratio & Short Volume

Short interest is the volume of Centogene shares that have been sold short but have not yet been covered or closed out. As of July 15th, investors have sold 81,700 shares of CNTG short. 0.69% of Centogene's shares are currently sold short. Learn More on Centogene's current short interest.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.69% of Centogene's floating shares are currently sold short.

Centogene saw a decrease in short interest in July. As of July 15th, there was short interest totaling 81,700 shares, a decrease of 16.8% from the previous total of 98,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Centogene currently has issued a total of 27,080,000 shares. Some of Centogene's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Centogene currently has a public float of 11,760,000 shares.

0.69% of Centogene's shares are currently sold short. Here is how the short interest of companies in the industry of "healthcare" compare to Centogene: Concord Medical Services Holdings Limited (0.16%), Psychemedics Co. (1.25%), The Oncology Institute, Inc. (3.37%), BioRestorative Therapies, Inc. (1.32%), OpGen, Inc. (0.19%), Kindly MD, Inc. (10.74%), Ontrak, Inc. (1.26%), Mangoceuticals, Inc. (9.13%), Agape ATP Co. (5.12%), Vsee Health, Inc. (5.75%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.13 billion), Royal Caribbean Cruises Ltd. ($2.77 billion), Moderna, Inc. ($2.76 billion), Coinbase Global, Inc. ($2.36 billion), Rivian Automotive, Inc. ($2.22 billion), Paychex, Inc. ($2.02 billion), Tractor Supply ($1.81 billion), Enphase Energy, Inc. ($1.65 billion), Chesapeake Energy Co. ($1.62 billion), and Lululemon Athletica Inc. ($1.58 billion). View all of the most shorted stocks.

Short selling CNTG is an investing strategy that aims to generate trading profit from Centogene as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Centogene occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CNTG, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CNTG, twice per month. The most recent reporting period available is July, 15 2024.